Claude Cimino v. Raymark Industries, Inc., Pittsburgh Corning Corporation and Asbestos Corporation Limited

151 F.3d 297
CourtCourt of Appeals for the Fifth Circuit
DecidedSeptember 21, 1998
Docket93-4452 through 93-4611
StatusPublished
Cited by145 cases

This text of 151 F.3d 297 (Claude Cimino v. Raymark Industries, Inc., Pittsburgh Corning Corporation and Asbestos Corporation Limited) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Claude Cimino v. Raymark Industries, Inc., Pittsburgh Corning Corporation and Asbestos Corporation Limited, 151 F.3d 297 (5th Cir. 1998).

Opinions

GARWOOD, Circuit Judge:

Before us are appeals and cross-appeals in personal injury and wrongful death damage suits against several manufacturers of asbestos-containing insulation products and some of their suppliers, the district court’s jurisdiction being based on diversity of citizenship and the governing substantive law being that of Texas. This is the same set of cases addressed in In re Fibreboard, 893 F.2d 706 (5th Cir.1990), but the judgments now before us result from a trial plan modified following that decision.1 Principally at issue on this appeal is the validity of that modified trial plan.

The district court originally consolidated the some 3,031 such cases then pending in the Beaumont Division of the Eastern District of Texas for trial of certain common issues under Fed.R.Civ.P. 42(a) and also certified a class action under Fed.R.Civ.P. 23(b)(3), the class generally consisting of the insulation and construction workers, then-survivors and household members, who were plaintiffs in those pending cases. As explained in more detail below, the trial plan ultimately implemented after Fibreboard consisted of three phases, generally described as follows; Phase I comprised a complete jury trial of the entire individual eases of the ten class representatives and [300]*300also a class-wide determination of issues of product defectiveness, warning, and punitive damages (including a multiplier as to each defendant). Phase II, which was to address exposure on a craft and job site basis, was dispensed with on the basis of a stipulation. In phase III, 160 different individual cases (“sample cases”), some from each of the five different allegedly asbestos-related diseases included in the entire group of underlying cases, were tried to two other juries to determine only each of those individual sample case plaintiffs’ respective actúal damages from their asbestos-related disease. Thereafter, and following a one-day bench hearing on the basis of which the district court determined that in each disease category the 160 sample cases were reliably representative of the cases involving the like disease among the remaining some 2,128 cases,2 the court ruled that each of these remaining 2,128 cases (the1 “extrapolation cases”) would be assigned by the court to one of the five disease categories and each would be entitled to judgment based on an amount of actual damages equal to the average of the verdicts rendered in those of the 160 sample cases involving the same disease category.3 Punitive damages in each case would be essentially based on the phase I verdict.

By the time of the phase I trial, many of the defendants had settled and others had taken bankruptcy or otherwise been disposed of, so only five remained, namely appellant Pittsburgh Corning Corporation (Pittsburgh Corning), Carey Canada, Celotex, Fibre-board, and appellant Asbestos Corporation, Limited (ACL). The case against ACL was tried to the court under the Foreign Sovereign Immunities Act, 28 U.S.C. §§ 1330(a), 1603(b). By the time the amount of the extrapolation case judgments was to be calculated, all defendants except Pittsburgh Corning and ACL had passed out of the case.4

Judgment was entered against ACL in only two of the ten class representative cases (and in none of either the phase III sample cases or the extrapolation cases). Judgment was actually entered against Pittsburgh Corning in a total of 157 cases, consisting of 9 of the class representative phase I cases, 143 of the, phase III sample cases, and 5 of the extrapolation cases (1 from each of the 5 different diseases included in the class).5 In these 157 cases, Pittsburgh Corning has been cast in judgment for a total of approximately $69,000,000.6 Pittsburgh Corning and ACL each appeal the referenced judgments entered against them, and the plaintiffs cross-appeal as to each.7 The issues presented in the ACL appeal and cross-appeal are few and narrow, and we address them last.

Pittsburgh Coming’s appeal presents essentially two groups of contentions, summarized as follows: first, those challenging the [301]*301implemented Cimino trial plan as a whole, particularly its asserted failure to properly try and determine individual causation and, in the five extrapolation cases, damages also, as to any plaintiffs other than the class representatives, assertedly contrary to our decision in Fibreboard and Texas substantive law and in derogation of Pittsburgh Coming’s Seventh Amendment and Due Process rights; and second, various other issues of a more particular and traditional sort. Plaintiffs’ cross-appeal presents issues of only the latter variety. We now turn to consider Pittsburgh Coming’s appeal, addressing first its attacks on the trial plan.

I.

PITTSBURGH CORNING APPEAL

A. Trial Plan Attack

1. Trial Plan

Initial Plan

The Cimino trial plan initially adopted by the district court, which we subsequently set aside in Fibreboard, also called for three phases. In phase I, the jury would decide which, if any, of each defendant’s products were defective as marketed and unreasonably dangerous, when each defendant knew or should have known workers or their household members were at risk, whether each defendant was guilty of gross negligence in marketing its offending product and, as to each defendant so guilty, a punitive damages multiplier. In phase II, the same jury would' decide the percentage of plaintiffs in the class exposed to each defendant’s products, the percentage of claims barred by limitations and other defenses, and would determine a lump sum amount of actual damages for each disease category for all plaintiffs in the class. The jury in this phase would also make a full determination of liability and damages with respect to each of the eleven class representatives individually. And the jury in phase II would also hear such evidence as the parties desired to present from up to thirty other illustrative plaintiffs, fifteen chosen by the defense and fifteen by plaintiffs, as well as expert testimony regarding the " total actual damages of the class, such expert testimony to be based, among other things, on questionnaires filled out by all class members and other discovery, including forty-five-minute oral depositions of class members taken by defendants. In phase III, to be non-jury, the court would distribute the awarded damages among the individual class members.8

Fibreboard

In Fibreboard, we found “no impediment to the trial of Phase I,” id. at 712, but held the balance of the plan invalid, stating:

“It infringes upon the dictates of Erie that we remain faithful to the law of Texas, and upon the separation of powers between the judicial and legislative branches.
“Texas has made its policy choices in defining the duty owed by manufacturers and suppliers of products to consumers. These choices are reflected in the

Free access — add to your briefcase to read the full text and ask questions with AI

Related

East Bay Sanctuary Covenant v. Donald Trump
993 F.3d 640 (Ninth Circuit, 2020)
Webb v. Special Electric Co., Inc.
370 P.3d 1022 (California Supreme Court, 2016)
Duran v. U.S. Bank National Assn.
325 P.3d 916 (California Supreme Court, 2014)
In Re: Deepwater Horizon
Fifth Circuit, 2013
Augustin v. Jablonsky
819 F. Supp. 2d 153 (E.D. New York, 2011)
Scottsdale Memorial Health Systems, Inc. v. Maricopa County
228 P.3d 117 (Court of Appeals of Arizona, 2010)
Hood ex rel. Mississippi v. Eli Lilly & Co.
671 F. Supp. 2d 397 (E.D. New York, 2009)
In Re Zyprexa Products Liability Litigation
671 F. Supp. 2d 397 (E.D. New York, 2009)
Maynor v. Dow Chemical Co.
671 F. Supp. 2d 902 (S.D. Texas, 2009)
Kremers v. THE COCA-COLA CO.
714 F. Supp. 2d 912 (S.D. Illinois, 2009)
MCI Sales and Service, Inc. v. Hinton
272 S.W.3d 17 (Court of Appeals of Texas, 2008)
Dukes v. Wal-Mart, Inc.
509 F.3d 1168 (Ninth Circuit, 2007)
Dukes v. Wal-Mart Store
Ninth Circuit, 2007
Allstate Insurance v. Receivable Finance Co.
501 F.3d 398 (Fifth Circuit, 2007)
Wagner v. General Motors Corp.
258 S.W.3d 749 (Supreme Court of Arkansas, 2007)
Gilcrease v. Garlock, Inc.
211 S.W.3d 448 (Court of Appeals of Texas, 2006)
Barasich v. Columbia Gulf Transmission Co.
467 F. Supp. 2d 676 (E.D. Louisiana, 2006)
Norwood v. Raytheon Co.
414 F. Supp. 2d 659 (W.D. Texas, 2006)
Presbyterian Church of Sudan v. Talisman Energy, Inc.
226 F.R.D. 456 (S.D. New York, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
151 F.3d 297, Counsel Stack Legal Research, https://law.counselstack.com/opinion/claude-cimino-v-raymark-industries-inc-pittsburgh-corning-corporation-ca5-1998.